Prime leukocyte filtration combined with conventional ultrafiltration in paediatric cardiopulmonary bypass

New Medicine

Volumn 6, Issue 1, 2003, Pages 16-22

  Bȩc, Leszek ^a   Karolczak, Maciej A ^a  

^a MEDICAL UNIVERSITY OF WARSAW   (Poland)

Author keywords

Cardiopulmonary bypass; Conventional ultrafiltration; Cytokines; Leukocyte activation; Leukocyte filtration; Systemic inflamatory response

Indexed keywords

CYTOKINE; HEPARIN; INTERLEUKIN 6; INTERLEUKIN 8; TUMOR NECROSIS FACTOR ALPHA;

ADOLESCENT; ANESTHESIA INDUCTION; ARTERIAL BLOOD; ARTICLE; BLEEDING; BLOOD SAMPLING; CARDIOPULMONARY BYPASS; CELL INFILTRATION; CHILD; CLINICAL ARTICLE; CONGENITAL HEART MALFORMATION; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HUMAN; INFANT; INTERMETHOD COMPARISON; LEUKOCYTE; MALE; MEASUREMENT; PEDIATRIC SURGERY; PLEURA EFFUSION; POSTOPERATIVE PERIOD; PROTEIN BLOOD LEVEL; SAMPLING; SUPERNATANT; THROMBOSIS; ULTRAFILTRATION;

EID: 19244377760     PISSN: 14270994     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Baksaas S.T. et al.: Leukocyte filtration during cardiopulmonary bypass hardly changed leukocyte counts and did not influence myeloperoxidase, complement cytokines or platelets. Perfusion 1998; 13(6):429-36.
2. Baksaas S.T. et al.: Leukocyte filtration during cardiopulmonary reperfusion in coronary artery bypass surgery. Perfusion 1999; 14(2):107-17.
3. Chiba Y. et al.: Effects of depletion of leukocytes and platelets on cardiac dyfunction after cardiopulmonary bypass. Ann. Thorac. Surg. 1998; 65:107-14.
4. Gu Y.J. et al.: Leukocyte depletion during cardiac operation: a new approach through the venous bypass circuit. Ann. Thorac. Surg. 199; 67:604-9.
5. Bolling K.S. et al.: Prevention of hypoxic reoxygenation injury with the use of a leukocyte - depleting filter. J. Thorac. Cardiovasc. Surg. 1997; 113(6):1081-9.
6. Wilson I.C. et al.: Leukocyte depletion in a neonatal model of cardiac surgery. Ann. Thorc. Surg. 1993; 55:12-9.
7. Miller B.E., Levy J.H.: The inflammatory response to cardiopulmonary bypass. J. Cardiovasc. Vasc. Anesth. 1997; 11(3):355-66.
8. Steiberg B.M. et al.: Heparin bonding of bypass circuits reduces cytokine release during cardiopulmonary bypass. Ann. Thorac. Surg. 1995; 60:525-9.
9. Monton C., Torres A.: Lung inflammatory response in pneumonia. Monaldi Arch. Chest Dis. 1998; 53(1):56-63.
10. deng M.C. et al.: Arterial and venous cytokine response to cardiopulmonary bypass for low risk CABG and relation to haemodynamics. Eur. J. Cardio-thorac Surg 1995; 9(1):22-9.
11. Wan S. et al.: Cancardioplegia menagement influence cytokine responses during clinical cardiopulmonary bypass? Ann. Thorac. Cardiovasc. Surg. 1999; 5(2):81-5.
12. Kiziltepe U. et al.: Effects of combined conventional and modifield ultrafiltration in adult patients. Ann. Thorac. Surg. 2001; 71:684-93.
13. Gaynor J.W.: Use of ultrafiltration during and after cardiopulmonary bypass in children. J. Thorac. Cardiovasc. Surg. 2001; 122:209-11.
14. Gaynor J.W.: Use of modifield ultrafiltration after repair of congenital heart defects. Semin. Thorac. Cardiovasc. Surg. Pediatr. Card. Surg. Annu. 1998; 1:81-90.
15. Keenan H.T. et al.: Pulmonary function after modified venovenous ultrafiltration in infants: a prospective, randomized trial. J. Thorac. Cardiovasc. Surg. 2000; 119:501-7.
16. Thompson L.N.D. et al.: A prospective randomized study comparing volume-standardized modified and conventional ultrafiltration in paediatric cardiac surgery. J. Thorac. Cardiovasc. Surg. 2001; 122:220-8.
17. Wang W. et al.: Modified ultrafiltration in pediatric cardiopulmonary bypass. Perfusion 1998; 13(5):304-10.
18. Saatvedt K. et al.: Ultrafiltration after cardiopulmonary bypass in children effects on haemodynamics, cytokines and complement. Cardiovasc-Res. 1996; 31(4):596-602.
19. Wang M.J. et al.: Efficacy of ultrafiltration in removing inflammatory mediators during paediatric cardiac operations. Ann. Thorac. Surg. 1996; 61(2):651-6.
20. Ferroni P. et al.: Platelet activation and cytokine production during hypothermic cardiopulmonary bypass - a possible correlation? Thromb. Haemost. 1998; 80(1):58-64.
21. Frering B. et al.: Circulating cytokines in patients undergoing normothermic cardiopulmonary bypass. J. Thorac. Cardiovasc. Surg. 1994; 108:636-41.
22. Finn A., Dreyer W.J.: Neurtophil adhesion and the inflammatory response induced by cardiopulmonary bypass. Cardiol. Young. 1993; 3:244-250.
23. Hierholzer C. et al.: Rapid and simultaneous activation of Stat.3 and production of interleukin 6 in resusciated haemorrhagic shock. Arch. Orthop. Trauma. Surg. 1999; 119(5-6):332-6.
24. Asimakopoulus G., Taylor K.M.: Effects of cardiopulmonary bypass on leukocyte and endothelial adhesion molecules. Ann. Thor. Surg. 1998; 66:2135-44.
25. Royston D.: The inflammatory response and extracorporeal circulation. J Cardiothorac. Vasc. Anesth. 1997; 11(3):341-54.
26. Ashraf S. et al.: "Low-dose" aprotinin modifies haemostasis but not proinflammatory cytokine release. Ann. Thorac. Surg. 1997; 63:68-73.
27. Ashraf S. et al.: Inflammatory mediators in adults undergoing cardiopulmonary bypass: comparison of centrifugal and roller pumps. Ann. Thorac. Surg. 1998; 65:480-4.
28. Hill G.E. et al.: The influence of cardiopulmonary bypass on cytokines and cell-cell communication. J. Cardiothorac. Vasc. Anesth. 1997; 11(3):367-75.
29. Mainwaring R.D. et al.: Complement activation and cytokine generation after modifield Fontan procedure. Ann. Thorac. Surg. 1998; 65(6):1715-20.
30. Bando K. et al.: Dilutional and modified ultrafiltration reduces pulmonary hypertension after operations for congenital heart disease: a prospective randomized study. J. Thorac. Cardiobasc. Surg. 1998. 1998; 115(3):517-25.
31. Sakurai H. et al.: Haemofiltration removes bradykinin generated in the priming blood in cardiopulmonary bypass during circulation. Ann. Thorac. Cardiovasc. Surg. 1998; 4(2):59-63.
32. Pearl J.M. et al.: Effect of modified ultarfiltration on plasma thromboxane B2, leukotrine B4, and endothelin-1 in infants undergoing cardiopulmonary bypass. Ann. Thorac. Surg. 1999; 68:1369-75.
33. Nagashima M. et al.: Effect of haemofiltraded whole blood pump priming on haemodynamics and respiratory function after the arterial switch operation in neonates. Ann. Thorac. Surg. 2000; 70:1901-6.
34. Smith J.J. et al.: Efficiency and safety of leukocyte filtration during cardiopulmonary bypass for cardiac surgery. Transfus. Sci. 1999; 20(3):151-65.
35. Bando K. et al.: Leukocyte depletion ameliorates free radical-mediated lung injury after cardiopulmonary bypass. J. Thorac. Cardiovasc. Surg. 1990; 99:873-7.
36. Cameron D.: Initiation of white cell activation during cardiopulmonary bypass; cytokines and receptors, J. Cardiovasc. Pharm. 1996; 27(suppl. 1):S1-S5.
37. Langley S.M. et al.: The effects of a leukocyte-depleting filter on cerebral and renal recovery after deep hypothermic circulatory arrest. J. Thorac. Cardiovasc. Surg. 2000; 119:1262-9.
38. Wan S. et al.: Inflamatory response to cardiopulmonary bypass; mechanisms involved and possible therapeutic strategies. Chest 1997; 112:676-92.
39. Lazar H.L. et al.: Role of leukocyte depletion during cardiopulmonary bypass and cardioplegic arrest. Ann. Thorac. Surg. 1995; 60:1745-8.
40. Kalawski R. et al.: Stimulation of neutrophil activation during coronary artery bypass grafting: comparison of crystalloid and blood cardioplegia. Ann. Thorac. Surg. 2001; 71:827-31.